|
Herceptin (Trastuzumab) Information (FAQ) Frequently Asked Questions (HI VALERIE 4-29-08 Send me your
data on Hercepin asap. Go Camp Carefree. Brian )
Herceptin (Trastuzumab): Beter known as HER2-positive which is a Breast Cancer Treatment. Herceptin Audio Track Explanation Video Click Here and Listen While you Surf. Why do I have a page about this? I have kept a journal www.IamFightingCancer.com of my very detailed medical journey which started with electrical shocks to the head. After a year assuming that it was Trigeminal Neuralgia one of the most painful disorders know to the medical field it was determined that I have a parotid gland tumor too deep to operate on. This is the salivary gland that is in your jaw on both sides of the face. If your body did not create saliva you can not eat. I have been there with a feeding tube for 4 months. Eventually after 33 radiations and 3 infusions of chemotherapy my tumor that was too deep to operate on was gone. I have added a lot since this site was originally made Then for about a year I had quarterly checkups with no discovery of further cancer. Then I developed a persistent cough for which the GP Doctor could not find a cause. I was sent for a CT Scan. I went to MD Anderson because they have all of my records. So now I have tumor metastasized in my lung along with increase fluid. A biopsy indicated it was the same type of cell that is treated with Herceptin in patients with breast cancer. I also was diagnosed with lesions on my spinal cord. These are being treated with a monthly dose After some chemo treatments it was determined that I had excessive liver enzymes 10 times more than normal. The chemo was cut off so other than a monthly dose for my bone structure I am not taking anything for my cancer except the herceptin. The last report showed the tumor slightly shrinking. Was this reduction cause by the herceptin treatment or was it caused by the chemo that I did have recently or was it from the nutrition diet change or ingredients in Immuno Power. The only pill I was taking was Zoloft for depression as my only medical pill so I was taken off that since the reduction of the chemo did not show a benefit in my liver problem. I went off the Zoloft cold turkey. My liver enzymes went down. The oncologist as assured it was due to the fact that the Zoloft was eliminated. So I want to learn more about the Herceptin. This compendium site will give a lot of information about Herceptin. I hope you learn something from this site. If that occurs please let me know. Brian Nelson 713-467-3025 Click: E-mail me |
1/3
You are at: http://www.IamFightingCancer.com/Herceptin-Trastuzumab/Medical-Information-FAQ.html ud 04/29/2008 04:23 AM -0500 Bookmark this page now!
|
Brian Nelson. Owner
31 Gessner Rd. , Houston, TX 77024
713-467-3025 Fax 713-467-3192
Click: E-mail meImportant words found on this political website.
Herceptin, Trastuzumab, Her2 Positive, Breast Cancer
Treatment, Fighting,
Misspelled words used to find this page 1 of 5.The important words found on this site include: You can find this site again by typing in the Google search engine the very unique word " 1nitpecreH " which is " Herceptin1 " backwards. Article Word Count __________ MSW _____ 1 YouTube.com 2 Alt Tags , 3 MSW 4 Metas/Title, Keywords Description 5 BB4/FormLetter 6 BB3/NIDAS, 7 BB1 & BB2 Follow Ups in NI. 8 URLChannelAdSense All Urls Completed. Delete 25. Old Low Ones |
|
|
7
New type of
chemotherapy drug approves for breast
cancer Today's topics include: Trastuzumab improves outcome in women with aggressive breast cancer, New type of chemotherapy drug approves for breast cancer treatment, Breast MRI detects more Ductal carcinoma in situ Adding Trastuzumab commmercially called Herceptin to chemotherapy appears to completeley eradicate tumors better than chemotherapy alon in women with HER2 positive inflammatory breast cancer. HER2 is a protein receptor that is present in certain in breast cancer. The researchers found a complete disappearance of the tumor was found in 55 percent of the women women who received trastuzumab and chemotherapy compared to 19% of women with inflammatory HER2 positive breast cancer who did not receive trastuzmab. Trastuzumab or herceptin is a member of a new category of drugs called targeted therapy agents. The food and drug association (FDA) recently approved a new chemotherapy agent Ixabepilone that does does not respond to standard chemotherapy agents. Ixabepilone is the first of tne nex classification of chemotherapy agents called epothilone. Ixabepilone is given every three weeks as a singe agent or in combinatioin with another chemotherapy drug called capecitabine. |
One a of the main side effects of the drugs is reversible peripheral nerve damage. Other side effects include a drop in blood count, muscles and joints pain, diarrhea and fatique. Ixabepilone is marketed commercially by Bristol-Myers Squib as lexmpra. http://www.youtube.com/watch?v=Z_qKG_R9FHQ |
2/3
1/3
Directory of Sites
Directory of Video Sites
Blue Box 1
![]()
ased on preclinical research, Herceptin is proposed to have up to 3
different types of activity:
![]()
1. May block
tumor cell growth
Herceptin binds to
HER2-positive
cancer cells and may block them from dividing and growing.
![]()
![]()

2. May target the cell for destruction by the
immune system
Herceptin attaches to the HER2-positive cancer cells and may signal
the body's immune system to destroy the cell.
![]()
![]()

![]()
3. May work with chemotherapy
Along with
chemotherapy (paclitaxel),
Herceptin may work to destroy HER2-positive cancer cells.
![]()
![]()

![]()
Important Safety Information
Herceptin treatment can result in reduced
heart function and congestive heart failure. The risk of
these heart problems was higher in people who received both
Herceptin and a certain type of chemotherapy (anthracycline). Your
doctor may need to stop or strongly consider stopping Herceptin if
you have a significant drop in your heart function.
Patients receiving Herceptin should be evaluated before and
frequently monitored throughout treatment for any drop in heart
function. Patients with pre-existing heart problems should be
monitored more frequently. Monitoring will not identify all patients
who will develop heart problems.
Serious infusion reactions and lung problems
have also been seen; rarely these have been fatal. Treatment
may be stopped if you begin to have a severe allergic reaction,
swelling, lung problems, inflammation of the lung, or severe
shortness of breath.
The worsening of low white blood cell counts associated with
chemotherapy has also occurred. The most common side effects
associated with Herceptin were fever, nausea, vomiting, infusion
reactions, diarrhea, infections, increased cough, headache, fatigue,
shortness of breath, rash, low white and red blood cells, and muscle
pain.
Because everyone is different, it is not possible to predict what
side effects any one person will have. If you have questions or
concerns about side effects, talk to your doctor.
How Do You Take Herceptin?
Herceptin is given through an
intravenous (IV) infusion
at your doctor's office or clinic.
![]()
Important Safety Information
Herceptin treatment can result in reduced
heart function and congestive heart failure. The risk of
these heart problems was higher in people who received both
Herceptin and a certain type of chemotherapy (anthracycline). Your
doctor may need to stop or strongly consider stopping Herceptin if
you have a significant drop in your heart function.
Patients receiving Herceptin should be evaluated before and
frequently monitored throughout treatment for any drop in heart
function. Patients with pre-existing heart problems should be
monitored more frequently. Monitoring will not identify all
patients who will develop heart problems.
Serious infusion reactions and lung
problems have also been seen; rarely these have been fatal.
Treatment may be stopped if you begin to have a severe allergic
reaction, swelling, lung problems, inflammation of the lung, or
severe shortness of breath.
The worsening of low white blood cell counts associated with
chemotherapy has also occurred. The most common side effects
associated with Herceptin were fever, nausea, vomiting, infusion
reactions, diarrhea, infections, increased cough, headache,
fatigue, shortness of breath, rash, low white and red blood cells,
and muscle pain.
Because everyone is different, it is not possible to predict what
side effects any one person will have. If you have questions or
concerns about side effects, talk to your doctor.
Blue Box
2